InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
3
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Rosenberg Noah L., Directeur Médical. Director active across 2 companies, notably Travere Therapeutics, Inc.. In total, 6 reports have been published. Split: 3 buys · 2 sells. Total volume traded: €56k. History available since 11 May 2021. The latest transaction was filed on 17 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rosenberg Noah L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
4,200 股@ US$4.91Common StockSEC:0001579649-26-000005:0
标准退出：2026年11月15日 (T+90)
2,030 股@ US$4.92Common StockSEC:0001579649-26-000005:1
标准退出：2026年11月16日 (T+90)
2,357 股@ US$4.2425100.0% 占其流量Common StockSEC:0001579649-25-000004:0
标准退出：2026年2月23日 (T+90)
4,500 股0Common StockSEC:0001209191-21-052083:0
1,250 股@ US$13.8171.1% 占其流量Common StockSEC:0001209191-21-048494:0
375 股@ US$19.1428.9% 占其流量Common StockSEC:0001209191-21-032319:0
6 条申报中的 6 条
About Rosenberg Noah L.
Noah L. Rosenberg is the Chief Medical Officer at Travere Therapeutics, Inc. He is responsible for medical strategy and clinical research. His expertise in medicine and drug development is essential for guiding the company's research initiatives.
